Stevens-Johnson Syndrome After Armodafinil Use.

Document Type

Article

Publication Title

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Abstract

We present the case of a 21-year-old woman in whom Stevens-Johnson syndrome (SJS) developed after initiation of armodafinil. Although this rare and life-threatening reaction is listed on armodafinil's label, no cases have been reported in the literature. This case, in addition to an update of the drug's label after post-marketing research, both support the link between armodafinil and SJS. Providers should maintain a high clinical suspicion for SJS when starting therapy to minimize associated morbidity and mortality by discontinuing armodafinil at the onset of first symptoms.

First Page

885

Last Page

887

DOI

10.5664/jcsm.7132

Publication Date

5-15-2018

Link to Full Text

Share

COinS